Article

Foundation assists keratoconic patients

Des Plaines, IL-The Internal Revenue Service has authorized the Foundation for Keratoconus Care to commence operations.

Des Plaines, IL-The Internal Revenue Service has authorized the Foundation for Keratoconus Care to commence operations.

The foundation financially assists keratoconic patients who are candidates for corneal implants (Intacs, Addition Technology), but who do not have the financial means to afford such a procedure. In general, any private patient of a U.S. licensed physician who, in the judgment of the physician, cannot afford the procedure, has no insurance coverage, and does not qualify for Medicaid or has been denied by Medicaid, is eligible for foundation assistance.

"There are a number of patients for whom the latest treatments are financially out of reach," said Michael R. Southard, executive director. "The foundation seeks to help restore these patients' sight by ensuring that they receive the necessary surgical procedure, regardless of their current financial situation."

Related Videos
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
© 2024 MJH Life Sciences

All rights reserved.